Literature DB >> 22346387

Susceptibility of group A beta-hemolytic streptococci in the lower St Lawrence region, Quebec.

A Desrosiers1, P Dolcé, P Jutras, L P Jetté.   

Abstract

OBJECTIVE: To determine the susceptibility of group A beta-hemolytic streptococci (GABHS) in the lower St Lawrence region, Quebec to different antibiotics, particularly macrolides, and to compare different antibiogram methods (disk diffusion, E-test and microdilution) and incubation atmospheres (ambient air and 5% carbon dioxide).
METHODS: A total of 384 strains of GABHS isolated from 377 patients (throat 335; other sites 49) from three hospitals in the lower St Lawrence region were analyzed for their susceptibility to erythromycin, clarithromycin, azithromycin, penicillin, clindamycin, cephalothin, rifampin and vancomycin by disk diffusion on Mueller-Hinton (MH) agar supplemented with 5% defibrinated sheep blood (MHB) at 35ºC in 5% carbon dioxide. Strains that were found to be intermediately resistant or resistant to one of the antibiotics by disc diffusion, strains from sites other than throat, and a sample of 97 pharyngeal strains were evaluated by E-test on MHB (35ºC, 5% carbon dioxide) for their susceptibility to the antibiotics erythromycin, clarithromycin, azithromycin, penicillin, clindamycin and ceftriaxone. In addition, minimum inhibitory concentrations (MICs) were determined for erythromycin and azithromycin by broth microdilution using MH broth supplemented with 2.5 % of lysed horse blood (35ºC, ambient air) on strains that were resistant or intermediately resistant to the macrolides (erythromycin, clarithromycin, azithromycin). An evaluation was also carried out on these strains to determine the influence of the incubating atmosphere (ambient air versus 5% carbon dioxide) on susceptibility results obtained by disk diffusion (erythromycin, clarithromycin and azithromycin) and E-test (erythromycin and azithromycin) methods.
RESULTS: Nine strains (2%) from nine patients (throat eight, pus one) were resistant to all macrolides as tested by three different techniques (disk diffusion, E-test and microdilution). All strains were susceptible to all the other antibiotics tested. For the strains intermediately resistant or resistant to macrolides, incubation in a 5% carbon dioxide atmosphere was associated with a reduction in the diameter of inhibition determined by disk diffusion (P<0.001) with frequent minor variations in interpretation, and with an increase in the MIC by E-test (P<0.001), which had no impact on interpretation.
CONCLUSIONS: Resistance of GABHS to macrolides was not common (2%) in the lower St Lawrence Region. GABHS susceptibility to erythromycin seemed to predict the susceptibility to the other macrolides. Significant variation in antibiogram results (disk diffusion and E-test) of GABHS susceptibility to macrolides was related to the incubation atmosphere and may have an impact on the interpretation of disk diffusion results.

Entities:  

Keywords:  Antibiogram; Beta-hemolytic streptococci; Group A streptococci; Macrolides; Resistance; Streptococcus pyogenes

Year:  1999        PMID: 22346387      PMCID: PMC3250706          DOI: 10.1155/1999/212549

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  24 in total

1.  Global surveillance of antibiotic resistance.

Authors:  T F O'Brien
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

2.  Resistance to erythromycin in group A streptococci.

Authors:  H Seppälä; A Nissinen; H Järvinen; S Huovinen; T Henriksson; E Herva; S E Holm; M Jahkola; M L Katila; T Klaukka
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

3.  Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci.

Authors:  H Seppälä; T Klaukka; R Lehtonen; E Nenonen; P Huovinen
Journal:  Clin Infect Dis       Date:  1995-12       Impact factor: 9.079

4.  Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes.

Authors:  L A Cone; D R Woodard; P M Schlievert; G S Tomory
Journal:  N Engl J Med       Date:  1987-07-16       Impact factor: 91.245

5.  Stepwise acquisition of multiple drug resistance by beta-hemolytic streptococci and difference in resistance pattern by type.

Authors:  Y Miyamoto; K Takizawa; A Matsushima; Y Asai; S Nakatsuka
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

6.  Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance.

Authors:  G Cornaglia; M Ligozzi; A Mazzariol; M Valentini; G Orefici; R Fontana
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

7.  Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.

Authors:  J Sutcliffe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

8.  The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study.

Authors:  C W Hoge; B Schwartz; D F Talkington; R F Breiman; E M MacNeill; S J Englender
Journal:  JAMA       Date:  1993-01-20       Impact factor: 56.272

9.  Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.

Authors:  G J Van Asselt; J H Sloos; R P Mouton; C P Van Boven; J A Van de Klundert
Journal:  J Med Microbiol       Date:  1995-11       Impact factor: 2.472

10.  Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

Authors:  D L Stevens; M H Tanner; J Winship; R Swarts; K M Ries; P M Schlievert; E Kaplan
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

View more
  1 in total

1.  Extremely high prevalence of erythromycin resistance of group a Beta hemolytic streptococci in mashhad (iran).

Authors:  Mohammad-Saeed Sasan; Fatemah Riyahi Zanian; Batol Birjandi; Mahbobe Naderinasab; Mohammad-Mahdi Ejtehadi
Journal:  Iran J Pediatr       Date:  2011-03       Impact factor: 0.364

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.